CVE-2023-44389

Zope management interface vulnerable to stored cross site scripting via the title property

Description

Zope is an open-source web application server. The title property, available on most Zope objects, can be used to store script code that is executed while viewing the affected object in the Zope Management Interface (ZMI). All versions of Zope 4 and Zope 5 are affected. Patches will be released with Zope versions 4.8.11 and 5.8.6.

Category

3.1
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.34%
Vendor Advisory github.com
Affected: zopefoundation Zope
Published at:
Updated at:

References

Link Tags
https://github.com/zopefoundation/Zope/security/advisories/GHSA-m755-gxxg-r5qh vendor advisory
https://github.com/zopefoundation/Zope/commit/21dfa78609ffd8b6bd8143805678ebbacae5141a patch
https://github.com/zopefoundation/Zope/commit/aeaf2cdc80dff60815e3706af448f086ddc3b98d patch

Frequently Asked Questions

What is the severity of CVE-2023-44389?
CVE-2023-44389 has been scored as a low severity vulnerability.
How to fix CVE-2023-44389?
To fix CVE-2023-44389, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-44389 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-44389 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-44389?
CVE-2023-44389 affects zopefoundation Zope.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.